ArticleBioanalysis

Advancing beyond stand-alone NAb assays: perspectives and regulatory impact of applying integrated immunogenicity assessment in drug development.

Kirstee Martin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.